Glipizide And Metformin Hcl
Product Images NDC 50090-1082

9 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Glipizide And Metformin Hcl (NDC 50090-1082). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

D37d20b-1bf7-4432-b26f-eaa223629580 (Ee5fdf68 Df2d 4965 8224 2c2df30f2f22 01)

D37d20b-1bf7-4432-b26f-eaa223629580 (Ee5fdf68 Df2d 4965 8224 2c2df30f2f22 01)
Chemical structure diagram of the active ingredient shown in the image, displaying atomic connectivity and functional groups in a 2D molecular format. This structural representation is associated with the glipizide and metformin hcl product by A-S Medication Solutions.*
FDA Label Image

Fd6f18e-67ad-4662-9a9c-04758aa16464 (Ee5fdf68 Df2d 4965 8224 2c2df30f2f22 02)

Fd6f18e-67ad-4662-9a9c-04758aa16464 (Ee5fdf68 Df2d 4965 8224 2c2df30f2f22 02)
Chemical structure of glipizide and metformin hydrochloride (HCl) showing the molecular arrangement with nitrogen, carbon, hydrogen atoms, and the associated hydrochloride component.*
FDA Label Image

Table 1 (Ee5fdf68 Df2d 4965 8224 2c2df30f2f22 03)

Table 1 (Ee5fdf68 Df2d 4965 8224 2c2df30f2f22 03)
A data table presenting pharmacokinetic parameters for metformin across different subject groups including healthy nondiabetic adults, adults with type 2 diabetes, elderly healthy nondiabetic adults, and renal-impaired adults. The table includes values for peak plasma concentration (Cmax), time to peak concentration (Tmax), and renal clearance with associated dosing information and study notes on fasting, dosing duration, and subject age ranges.*
FDA Label Image

Table 2 (Ee5fdf68 Df2d 4965 8224 2c2df30f2f22 04)

Table 2 (Ee5fdf68 Df2d 4965 8224 2c2df30f2f22 04)
A data table comparing clinical results for Glipizide 5 mg tablets, Metformin 500 mg tablets, and two strengths of Glipizide and Metformin HCl combination tablets (2.5 mg/250 mg and 2.5 mg/500 mg). The table shows mean doses, baseline and final means, adjusted mean changes from baseline, differences between drugs, and percentages of patients achieving specific hemoglobin A1c and fasting plasma glucose levels.*
FDA Label Image

Table 3 (Ee5fdf68 Df2d 4965 8224 2c2df30f2f22 05)

Table 3 (Ee5fdf68 Df2d 4965 8224 2c2df30f2f22 05)
A data table comparing mean final doses, hemoglobin A1c percentages, and fasting plasma glucose levels for Glipizide 5 mg tablets, Metformin 500 mg tablets, and Glipizide and Metformin HCl 5 mg/500 mg tablets. The table displays baseline means, adjusted means, mean changes, and percentage of patients with final HbA1c below 7%, with statistical differences noted in some comparisons.*
FDA Label Image

Table 4 (Ee5fdf68 Df2d 4965 8224 2c2df30f2f22 06)

Table 4 (Ee5fdf68 Df2d 4965 8224 2c2df30f2f22 06)
A data table presenting the number and percentage of patients experiencing various adverse events, such as upper respiratory infection, diarrhea, dizziness, hypertension, and nausea/vomiting, across four groups treated with glipizide 5 mg tablets, metformin 500 mg tablets, and two different glipizide and metformin HCl combination tablets.*
FDA Label Image

Table 5 (Ee5fdf68 Df2d 4965 8224 2c2df30f2f22 07)

Table 5 (Ee5fdf68 Df2d 4965 8224 2c2df30f2f22 07)
A data table presenting the number and percentage of patients experiencing various adverse events when treated with Glipizide 5 mg tablets, Metformin 500 mg tablets, and a combination of Glipizide and Metformin HCl 5 mg/500 mg tablets. The adverse events listed include diarrhea, headache, upper respiratory infection, musculoskeletal pain, nausea/vomiting, abdominal pain, and urinary tract infections (UTI). The table also notes dosage information for glipizide and combined treatments.*
FDA Label Image

Logo (Ee5fdf68 Df2d 4965 8224 2c2df30f2f22 10)

FDA Label Image

Label Image (Lbl500901082)

Label Image (Lbl500901082)
Label for glipizide and metformin hcl 5 mg/500 mg tablets from A-S Medication Solutions. The label displays the product number 5993-0, package size of 180 tablets, and storage instructions to keep between 68-77 degrees Fahrenheit. Manufacturer information includes Sandoz Inc., Kalamazoo, MI. The label also features dosage and packaging details with barcode and lot number.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.